[111In]In-FL-020

N/A

Report date: 2025/12/02 14:06:59
NME

Base Information

Drug Name[111In]In-FL-020
Drug Alias NameN/A
ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Radioactive diagnostic agent +[4] 
Mechanisms of ActionIonising radiation emittersProstate-Specific Membrane Antigen modulatorsSingle-photon emission-computed tomography enhancers
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsProstatic Neoplasms, Castration-Resistant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesFull Life Technologies Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFull Life Technologies Ltd
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms, Castration-Resistant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A